Patents by Inventor Steven D. Young

Steven D. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4831035
    Abstract: Certain substituted hexahydroarylquinolizines and pharmaceutically acceptable salts thereof are peripherally selective .alpha..sub.2 -adrenoceptor antagonists. The compounds are adapted to be employed for the treatment of certain pathological disorders such as hypertension, diabetes, disorders involving platelet aggregation and the like without side effects attributable to effect on the central nervous system.
    Type: Grant
    Filed: July 27, 1987
    Date of Patent: May 16, 1989
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Joel R. Huff, Susan J. deSolms, Joseph P. Vacca, Jonathan M. Wiggins, Steven D. Young
  • Patent number: 4824849
    Abstract: Substituted hexahydro arylquinolizines and pharmaceutically acceptable salts thereof are selective .alpha..sub.2 -adrenergic receptor antagonists and thereby useful as antidepressants, antihypertensives, ocular antihypertensives, antidiabetics, platelet aggregation inhibitors, antiobesity agents, and modifiers of gastrointestinal motility.
    Type: Grant
    Filed: August 28, 1987
    Date of Patent: April 25, 1989
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Joel R. Huff, Joseph P. Vacca, Steven D. Young, Jane deSolms, James P. Guare, Jr.
  • Patent number: 4758577
    Abstract: Novel 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds are disclosed. The compounds have the property of inhibiting calcium induced contraction of the smooth muscle.
    Type: Grant
    Filed: April 5, 1984
    Date of Patent: July 19, 1988
    Assignee: Merck & Co., Inc.
    Inventor: Steven D. Young
  • Patent number: 4710504
    Abstract: Substituted hexahydro arylquinolizines and pharmaceutically acceptable salts thereof are selective .alpha..sub.2 -adrenergic receptor antagonists and thereby useful as antidepressants, antihypertensives, ocular antihypertensives, antidiabetics, platelet aggregation inhibitors, antiobesity agents, and modifiers of gastrointestinal motility.
    Type: Grant
    Filed: April 4, 1986
    Date of Patent: December 1, 1987
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, Joel R. Huff, Joseph P. Vacca, Steven D. Young, Jane deSolms, James P. Guare, Jr.
  • Patent number: 4616023
    Abstract: Pharmaceutical compositions comprising 4-(dibenzo[a,d]cycloalkenyl)piperazine compounds and the use of said piperazine compounds for treatment of certain cardiovascular disorders are disclosed.
    Type: Grant
    Filed: February 21, 1985
    Date of Patent: October 7, 1986
    Assignee: Merck & Co., Inc.
    Inventors: David C. Remy, Steven D. Young
  • Patent number: 4593033
    Abstract: Novel substituted indeno[2,1-c] pyridine compounds useful as calcium channel blockers, pharmaceutical compositions thereof, and methods of treatment are disclosed.
    Type: Grant
    Filed: April 24, 1985
    Date of Patent: June 3, 1986
    Assignee: Merck & Co., Inc.
    Inventors: George D. Hartman, Wasyl Halczenko, Steven D. Young
  • Patent number: 4567268
    Abstract: A facile process for the preparation of certain tetrahydrofuro[3,4-b]pyridines is described. The compounds have pharmacological properties useful in the study and treatment of cardiovascular diseases.
    Type: Grant
    Filed: April 3, 1984
    Date of Patent: January 28, 1986
    Assignee: Merck & Co., Inc.
    Inventor: Steven D. Young
  • Patent number: 4542138
    Abstract: 6H-3,11b-Dihydrocarbalkoxy-5,7-dioxobenzo[6,7]cyclohepta[1,2-c]pyridine compounds represented by the formula: ##STR1## wherein G is lower alkyl or halogen; R is lower alkyl, R' is hydrogen, lower alkyl, and n is from 0 to 2 and a process for their preparation are disclosed. The compounds have the property of inhibiting calcium induced contraction of the smooth muscle.
    Type: Grant
    Filed: May 8, 1984
    Date of Patent: September 17, 1985
    Assignee: Merck & Co., Inc.
    Inventor: Steven D. Young